Further, none of these studies had patients stratified pretreatment for relevant predictors of HCC risk, like age, hepatitis severity, alpha-fetoprotein (AFP) levels and co-morbidities, therefore making a comparison of the outcomes between treated and untreated patients difficult. This evidence concerns the gene AFP and Hepatitis.